首页|河北省医院临床用血质量控制现状分析

河北省医院临床用血质量控制现状分析

Current situation of quality control of clinical blood use in hospitals in Hebei province

扫码查看
目的 通过比较河北省不同级别医院之间临床用血质量控制现状,找寻实际工作中存在的问题和不足,提出加强医疗机构临床用血管理对策.方法 选择 2020 年河北省 602 家医院(三级医院 86 家,二级医院 451 家,一级医院 65 家)为调查对象.依据《国家卫生健康委办公厅关于印发临床用血质量控制指标(2019 年版)的通知》,制定河北省临床用血质量控制指标填报表,各医院按照要求逐一填写,并将资料输入Excel表格后上报省临床用血质控中心,对资料进行归纳分析.结果 《临床输血申请单》合格率在三级、二级、一级医院分别为 98.2%、96.41%、97.21%(χ2=2160.24,P<0.05).输血相容性检测项目室内质控率在三级、二级、一级医院分别为 98.30%、91.75%、90.05%(χ2=50.71,P<0.05),输血相容性检测室间质评项目参加率分别为 99.73%、98.18%、94.01%(χ2=37.5,P<0.05),受血者标本血型复查率分别为 102.40%、101.39%、98.98%(χ2=5598.49,P<0.05).千输血人次输血不良反应上报在三级、二级、一级医院分别为 1.76、3.86,2.07(χ2=258.94,P<0.05).自体输血开展率在三级、二级、一级医院分别为 41.86%、5.10%、0(χ2=118.33,P<0.05).总手术患者自体输血率在三级、二级、一级医院分别为 9.43%、2.71%、0%(χ2=5813.11,P<0.05).结论 河北省三级医院临床用血质量控制在多方面明显好于二级及以下医院,二级及其以下医院输血管理制度不健全,临床用血管理不力,临床用血多个环节仍然存在安全隐患,有待进一步加强.
Objective To find shortcomings and deficiencies by comparing present situation of quality control of clinical blood use among hospitals of different class in Hebei province,and put forward a strategy to strengthen management for clinical blood use.Methods A total of 602 hospitals including 86 third-level hospitals,451 second-level hospitals,65 first-level hospitals in Hebei province were selected from January to December 2020.A table of indicators of quality control for clinical blood use was made based on the"Notice of the General Office of the National Health Commission on Issuing Clinical Blood Quality Control Indicators(2019 Edition)",and filled in by each hospital.The tables were sumitted to clinical blood quality control center in Hebei province after inputting the data into the Excel form,and the data was analyzed statistically.Results The qualified rate of clinical blood transfusion application forms in the third-level,second-level,and first-level hospitals was 98.2%,96.41%,97.21%,respectively(χ2=2160.24,P<0.05).The respective internal quality control rate in items for transfusion compatibility test was 98.30%,91.75%,90.05%,respectively(χ2==50.71,P<0.05).The respective participation rate of external quality assessment items was 99.73%,98.18%,94.01%,respectively(χ2=37.5,P<0.05).The respective blood group reexamination rate of blood recipient samples was 102.40%,101.39%,98.98%,respectively(χ2=5598.49,P<0.05).The respective report number of adverse reactions in transfusion per 1000 units was 1.76,3.86,2.07,respectively(χ2=258.94,P<0.05).The respective autotransfusion rate was 41.86%,5.10%,0,respectively(χ2=118.33,P<0.05).The respective autotransfusion rate in total surgical patients was 9.43%,2.71%,0,respectively(χ2=5813.11,P<0.05).Conclusion Third-level hospital is superior to second-level hospital and first-level hospital in quality control of clinical blood use.Management system is imperfect,and management level is poor in second-level hospital and first-level hospital.There are potential safety risks in multiple links of clinical blood use.

clinical blood usequality controlmanagement

宋俊贞、赵志宏、李茵、张淑艳

展开 >

050071 石家庄市,河北省血液中心临床用血指导办公室

临床用血 质量控制 管理

河北省卫生健康委员会医学科学研究指导性课题

20200840

2024

河北医药
河北省医学情报研究所

河北医药

CSTPCD
影响因子:1.075
ISSN:1002-7386
年,卷(期):2024.46(9)
  • 20